Back to Journals » Drug Design, Development and Therapy
Drug Design, Development and Therapy
Editor-in-Chief: Professor Frank Boeckler
An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
This journal offers Accelerated Publication.
Articles:
- View all (5624)
- Volume 20, 2026 (393)
- Volume 19, 2025 (762)
- Volume 18, 2024 (430)
- Volume 17, 2023 (283)
- Volume 16, 2022 (316)
- Volume 15, 2021 (399)
- Volume 14, 2020 (477)
- Volume 13, 2019 (387)
- Volume 12, 2018 (382)
- Volume 11, 2017 (330)
- Volume 10, 2016 (374)
- Volume 9, 2015 (543)
- Volume 8, 2014 (231)
- Volume 7, 2013 (143)
- Volume 6, 2012 (42)
- Volume 5, 2011 (40)
- Volume 4, 2010 (35)
- Volume 3, 2009 (27)
- Volume 2, 2008 (29)
- Volume 1, 2007 (1)
Latest articles:
- 5 records -
Identification of Antibacterial Hits Associated with Penicillin-Binding Protein 2 in Escherichia coli Using a Comprehensive Property Spectrum and Fivefold Maximum Drug-Likeness Strategy
Zhu H, Du S, Yang Q, Xu L, Shi W
Drug Design, Development and Therapy 2026, 20:595430
Published Date: 9 June 2026
Determination of the ED90 for Epidural Hydromorphone and Morphine for Postoperative Pain Using a Biased-Coin Up-and-Down Sequential Design After Elective Cesarean Delivery
Tang X, Liang Y, Hu Y, Li P, Wang J, Wang Y, Xie M
Drug Design, Development and Therapy 2026, 20:588767
Published Date: 9 June 2026
Paeoniflorin as a Promising Therapeutic Candidate in Intestinal Diseases: Experimental Evidence, Mechanistic Insights, and Translational Perspectives
Chang C, Xue J, Xu Z, Hou G
Drug Design, Development and Therapy 2026, 20:617375
Published Date: 9 June 2026
Age-Stratified ED95 of Remimazolam Tosilate for Moderate Sedation in Pediatric Patients: A Biased Coin Design Study
Zhu B, Meng W, Pan K, Peng L, Chen X, Wang S, Yang C
Drug Design, Development and Therapy 2026, 20:613464
Published Date: 8 June 2026
Oliceridine in the Prevention of Catheter-Related Bladder Discomfort: A Single-Center, Randomized, Double-Blind, Prospective Trial
Jiang RJ, Gao S, Yang Z, Bin XY, Cheng L, Liu SX
Drug Design, Development and Therapy 2026, 20:605184
Published Date: 8 June 2026